Bhk Investment Advisors, LLC Abb Vie Inc. Transaction History

Bhk Investment Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 31, 2019	SELL	$62.98 - $75.72 $209,219 - $251,541	-3,322 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$65.7 - $83.98 $13,140 - $16,796	200 Added 6.41%	3,322 $242,000
Q1 2019 May 03, 2019	BUY	$77.14 - $90.79 $240,831 - $283,446	3,122 New	3,122 $252,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Bhk Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bhk Investment Advisors, LLC with notifications on news.